Collateral

Q&A with encapsia’s Executive Director of Business Development Temitope Keyes   Superior innovation and performance are achieved with diverse teams that bring new perspectives and skill sets. In acknowledgment of International Women’s Day, we’re shining the spotlight on women in…

The increasing complexity of modern trials demands more intensive data capture. Innovative study designs seek to minimize patient exposure to potential risks, improve convenience and shorten therapy time-to-market —requiring collecting and assimilating more data points than ever before. Data now…

Clinical trials are slow, costly, and inefficient. Different studies put the average cost of drug development at $1.3 to $2.8 billion— with clinical trials accounting for about two-thirds.  Traditional trials burden patients with financial and time-costly travel requirements. On average,…